ADVM-063
/ Adverum Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 23, 2019
Adverum Biotechnologies announces data presentations at the European Society of Gene and Cell Therapy (ESGCT) 2019 Congress
(GlobeNewswire)
- "Adverum Biotechnologies...today announced presentations on the company’s gene therapy programs to be presented at the European Society of Gene and Cell Therapy (ESGCT) 2019 Congress in Barcelona, Spain...Feasibility of Gene Therapy for Friedreich Ataxia-Associated Cardiomyopathy in Non-Human Primates: Evaluation of Delivery Route, Biodistribution and Expression Following AAVRh.10.FXN Administration."
Preclinical
1 to 1
Of
1
Go to page
1